278 related articles for article (PubMed ID: 24722173)
1. Testosterone, aging and survival: biomarker or deficiency.
Shores MM; Matsumoto AM
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):209-16. PubMed ID: 24722173
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis.
Alexander GC; Iyer G; Lucas E; Lin D; Singh S
Am J Med; 2017 Mar; 130(3):293-305. PubMed ID: 27751897
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy and cardiovascular risk: advances and controversies.
Morgentaler A; Miner MM; Caliber M; Guay AT; Khera M; Traish AM
Mayo Clin Proc; 2015 Feb; 90(2):224-51. PubMed ID: 25636998
[TBL] [Abstract][Full Text] [Related]
4. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and cardiovascular disease.
Schooling CM
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):202-8. PubMed ID: 24722171
[TBL] [Abstract][Full Text] [Related]
6. Exogenous testosterone, cardiovascular events, and cardiovascular risk factors in elderly men: a review of trial data.
Carson CC; Rosano G
J Sex Med; 2012 Jan; 9(1):54-67. PubMed ID: 21676183
[TBL] [Abstract][Full Text] [Related]
7. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
[TBL] [Abstract][Full Text] [Related]
8. Injection testosterone and adverse cardiovascular events: A case-crossover analysis.
Layton JB; Li D; Meier CR; Sharpless JL; Stürmer T; Brookhart MA
Clin Endocrinol (Oxf); 2018 May; 88(5):719-727. PubMed ID: 29446829
[TBL] [Abstract][Full Text] [Related]
9. Beneficial and adverse effects of testosterone on the cardiovascular system in men.
Ruige JB; Ouwens DM; Kaufman JM
J Clin Endocrinol Metab; 2013 Nov; 98(11):4300-10. PubMed ID: 24064693
[TBL] [Abstract][Full Text] [Related]
10. Testosterone and cardiovascular disease--the controversy and the facts.
Morgentaler A; Feibus A; Baum N
Postgrad Med; 2015 Mar; 127(2):159-65. PubMed ID: 25708023
[TBL] [Abstract][Full Text] [Related]
11. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels.
Vigen R; O'Donnell CI; Barón AE; Grunwald GK; Maddox TM; Bradley SM; Barqawi A; Woning G; Wierman ME; Plomondon ME; Rumsfeld JS; Ho PM
JAMA; 2013 Nov; 310(17):1829-36. PubMed ID: 24193080
[TBL] [Abstract][Full Text] [Related]
12. Testosterone therapy and cardiovascular risk.
Walsh JP; Kitchens AC
Trends Cardiovasc Med; 2015 Apr; 25(3):250-7. PubMed ID: 25467243
[TBL] [Abstract][Full Text] [Related]
13. Testosterone and cardiovascular disease risk.
Yeap BB
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):193-202. PubMed ID: 25887389
[TBL] [Abstract][Full Text] [Related]
14. Combination of low free testosterone and low vitamin D predicts mortality in older men referred for coronary angiography.
Lerchbaum E; Pilz S; Boehm BO; Grammer TB; Obermayer-Pietsch B; März W
Clin Endocrinol (Oxf); 2012 Sep; 77(3):475-83. PubMed ID: 22356136
[TBL] [Abstract][Full Text] [Related]
15. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
[TBL] [Abstract][Full Text] [Related]
16. In brief: testosterone and cardiovascular risk.
Med Lett Drugs Ther; 2014 Mar; 56(1437):17. PubMed ID: 24589496
[No Abstract] [Full Text] [Related]
17. Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men.
Yeap BB
Asian J Androl; 2018; 20(2):109-114. PubMed ID: 29199649
[TBL] [Abstract][Full Text] [Related]
18. Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging?
Gungor O; Kircelli F; Carrero JJ; Asci G; Toz H; Tatar E; Hur E; Sever MS; Arinsoy T; Ok E
Clin J Am Soc Nephrol; 2010 Nov; 5(11):2018-23. PubMed ID: 20651153
[TBL] [Abstract][Full Text] [Related]
19. Testosterone and the Heart.
Goodale T; Sadhu A; Petak S; Robbins R
Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
[TBL] [Abstract][Full Text] [Related]
20. Adverse events associated with testosterone administration.
Basaria S; Coviello AD; Travison TG; Storer TW; Farwell WR; Jette AM; Eder R; Tennstedt S; Ulloor J; Zhang A; Choong K; Lakshman KM; Mazer NA; Miciek R; Krasnoff J; Elmi A; Knapp PE; Brooks B; Appleman E; Aggarwal S; Bhasin G; Hede-Brierley L; Bhatia A; Collins L; LeBrasseur N; Fiore LD; Bhasin S
N Engl J Med; 2010 Jul; 363(2):109-22. PubMed ID: 20592293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
